The Psychopharmacology of Hallucinogens

@article{Abraham1996ThePO,
  title={The Psychopharmacology of Hallucinogens},
  author={Henry David Abraham and Andrew M. Aldridge and Prashant Gogia},
  journal={Neuropsychopharmacology},
  year={1996},
  volume={14},
  pages={285-298}
}

The adverse effects of hallucinogens from intramural perspective.

  • E. FrecskaL. E. Luna
  • Medicine
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology
  • 2006
TLDR
Safety information available in the literature on hallucinogen use is reviewed, and those data from the reported complications of their abuse are sorted out, in anticipation of supportive regulatory changes for the use of hallucinogens in well controlled studies and strictly supervised clinical trials.

The behavioral pharmacology of hallucinogens.

Hallucinogenic drugs attenuate the subjective response to alcohol in humans

TLDR
It is proposed that LSD's effect on alcohol intoxication may involve interactions with various serotonergic and/or dopaminergic receptor systems.

[Hallucinogen-induced psychological disorders].

TLDR
An overview of the current research on hallucinogen induced psychiatric disorders is provided and clinical relevance of flashback phenomena as post-hallucinogenic psychiatric disorder has to be disputed.

Hallucinogens, serotonin and obsessive-compulsive disorder.

TLDR
Clinical and preclinical data suggest that activation of 5-HT2 receptors by hallucinogens may lead to acute reduction of, as well as possible longer-lasting beneficial effects on, the symptoms of OCD.

Ketamine and Phencyclidine

TLDR
This chapter discusses management of the physiological and psychological consequences of use, as well as treatment of addiction of ketamine and phencyclidine.

Hallucinogen-persisting perception disorder

TLDR
Based on its hypothesized neuroprotective and mood-stabilizing effects, the antiepileptic lamotrigine may offer a promising new approach in the treatment of HPPD.

The psychotomimetic effects of PCP , LSD and MDMA : Pharmacological models of schizophrenia ?

TLDR
The primary question addressed herein, whether PCP-induced psychosis is a valid model of schizophrenia, gives rise to additional questions about the validity of ketamine challenge at subanaesthetic doses in humans as a model of PCP psychosis, and in turn, questions aboutThe validity of drug-induced changes in non-human animals (rodents, monkeys) treated with PCP and its analogues (ketamine or dizocilpine [MK-801]) as models of PCPs psychosis.

Metabolism of lysergic acid diethylamide (LSD): an update

TLDR
Lysergic acid diethylamide is the most potent hallucinogen known and its pharmacological effect results from stimulation of central serotonin receptors (5-HT2) and its metabolism is discussed, by presenting all metabolites as well as clinical and toxicological relevance.
...

References

SHOWING 1-10 OF 91 REFERENCES

Adverse consequences of lysergic acid diethylamide.

TLDR
Current data confirm earlier findings of long lasting psychopathology arising in vulnerable individuals from the use of LSD, and a hypothetical long term molecular mechanism of adverse effects is proposed.

Pharmacology and Classification of LSD-like Hallucinogens

Hallucinogens of the LSD-type have been used since antiquity (Schultes, 1969, 1970a, b). Peyote and mushrooms containing psilocin (Heim and Wasson, 1958; Wasson, 1959) were used by Indians of the

Prolonged adverse reactions to lysergic acid diethylamide.

TLDR
It is the impression that these hallucinogenic drugs are unique tools in the study of altered states of awareness, perception, and ideation, and the question of their therapeutic value remains unsettled since no definitive study has been reported.

Prolonged adverse reactions to LSD in psychotic subjects.

TLDR
The descriptions of prolonged adverse effects of lysergic acid diethylamide generally include spontaneous recurrences of the acute LSD experience, persistent psychotic decompensations, induced depression with attempted and completed suicides, and multihabituation.

PERSISTENT HALLUCINOSIS FOLLOWING REPEATED ADMINISTRATION OF HALLUCINOGENIC DRUGS.

TLDR
A further case of a chronic hallucinatory state or hallucinosis which is occasionally seen after repeated drug administrations is added here.

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

  • R. Strassman
  • Psychology, Medicine
    The Journal of nervous and mental disease
  • 1984
TLDR
The basic pharmacology of the major synthetic psychedelic compounds (primarily lysergic acid diethylamide [LSD]-25) is described and reference is made to their potentially beneficial psychological effects.

The experimental use of psychedelic (LSD) psychotherapy.

The history of research with psychedelic drugs has produced a variety of methods for their use and conflicting claims about results. First came the wave of excitement among experimentalists in the

Acute psychosis induced by psychotomimetic drug abuse. II. Neurochemical findings.

  • M. Bowers
  • Psychology, Medicine
    Archives of general psychiatry
  • 1972
TLDR
Compared to nondrug-induced psychotic patients and inmate controls the drug-induced patients gave evidence of decreased central 5HIAA formation, findings analagous to those obtained following the administration of LSD-like drugs to animals.

The pharmacology of hallucinogens.

TLDR
In the context of the yawning abyss of ignorance and speculation which separates biochemical and behavioural data, the contribution of these few observations on psychotomimetics may be regarded as vanishingly small.

Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization.

TLDR
A sudden surge of admissions to the Bellevue Psychiatric Division after ingestion of d-lysergic acid diethylamide (LSD) prompted us to review the history of this drug.
...